ITIA Press Release, September 6, 2022

The International Tennis Integrity Agency (ITIA) has confirmed that Juan-Carlos Osorio Hernández, a 39-year-old Ecuadorian tennis player, has been provisionally suspended under Article 7.12.1 of the 2022 Tennis Anti-Doping Programme (TADP). The ITIA sent the player a pre-charge notice of an Anti-Doping Rule Violation on 27 July under Article 2.1 of the Programme (presence of a Prohibited Substance in a Player’s Sample) and Article 2.2 (Use of a Prohibited Substance without a valid TUE), confirming they were provisionally suspended from that date.

Osorio Hernández, who is currently unranked, provided a sample whilst competing at the WTT M15 in Ecuador in June 2022. Subsequent analysis found that the sample contained a metabolite of Methasterone. Methasterone is a non-specified prohibited substance listed in the 2022 World Anti-Doping Agency (WADA) Prohibited List. Adverse Analytical Findings for non-specified substances carry a mandatory provisional suspension. The player was offered the opportunity to request that the B sample was analysed to see if it confirmed the A sample. While provisionally suspended, the player is ineligible to compete in or attend any tennis events authorised, organised or sanctioned by the governing bodies of the sport.